These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 28723865

  • 1. MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer.
    Yu S, Qin X, Chen T, Zhou L, Xu X, Feng J.
    Anticancer Drugs; 2017 Sep; 28(8):852-860. PubMed ID: 28723865
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9.
    Liu B, Wang R, Liu H.
    Biomed Res Int; 2021 Sep; 2021():6622342. PubMed ID: 34055989
    [Abstract] [Full Text] [Related]

  • 4. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y, Xu T, Zhong S, Wang B, Zhang H, Wang X, Wang P, Li G, Yang S.
    Life Sci; 2019 Dec 15; 239():116984. PubMed ID: 31647948
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N, Guo Z, Wu X, Tian Y, Li Y, Geng Y, Yu Y.
    Respir Res; 2021 Sep 18; 22(1):248. PubMed ID: 34537072
    [Abstract] [Full Text] [Related]

  • 10. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
    Pan X, Chen Y, Shen Y, Tantai J.
    Cell Death Dis; 2019 Jun 03; 10(6):429. PubMed ID: 31160576
    [Abstract] [Full Text] [Related]

  • 11. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
    Liu X, Zhou X, Chen Y, Huang Y, He J, Luo H.
    Neoplasma; 2020 Jan 03; 67(1):147-157. PubMed ID: 31686523
    [Abstract] [Full Text] [Related]

  • 12. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X.
    Exp Mol Pathol; 2021 Jun 03; 120():104633. PubMed ID: 33753110
    [Abstract] [Full Text] [Related]

  • 13. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression.
    Sui C, Meng F, Li Y, Jiang Y.
    J Transl Med; 2015 Apr 28; 13():132. PubMed ID: 25927928
    [Abstract] [Full Text] [Related]

  • 14. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
    Qi MM, Ge F, Chen XJ, Tang C, Ma J.
    Eur Rev Med Pharmacol Sci; 2019 Jun 28; 23(12):5242-5250. PubMed ID: 31298375
    [Abstract] [Full Text] [Related]

  • 15. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
    Yuwen DL, Sheng BB, Liu J, Wenyu W, Shu YQ.
    Eur Rev Med Pharmacol Sci; 2017 Jun 28; 21(11):2650-2658. PubMed ID: 28678319
    [Abstract] [Full Text] [Related]

  • 16. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H, Yao J, Wang Y, Ni B.
    Drug Deliv; 2022 Dec 28; 29(1):1257-1271. PubMed ID: 35467477
    [Abstract] [Full Text] [Related]

  • 17. TNFAIP2 Promotes Non-Small Cell Lung Cancer Cells and Targeted by miR-145-5p.
    Li J, Song Y, Yu B, Yu Y.
    DNA Cell Biol; 2020 Jul 28; 39(7):1256-1263. PubMed ID: 32456459
    [Abstract] [Full Text] [Related]

  • 18. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
    Sun W, Ping W, Tian Y, Zou W, Liu J, Zu Y.
    Cell Physiol Biochem; 2018 Jul 28; 51(5):2160-2171. PubMed ID: 30522099
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
    Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X, Shen B, Liu S, Yan D, Feng J.
    Int J Nanomedicine; 2017 Jul 28; 12():3721-3733. PubMed ID: 28553110
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy.
    Hua L, Zhu G, Wei J.
    Cell Biol Int; 2018 Sep 28; 42(9):1240-1249. PubMed ID: 29851226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.